Drug Delivery · 2021 · 25 citations · 27 references
PharmacyPharmacokineticsPharmacologyChemotherapyDrug DeliveryPharmacokinetics Of Anticancer AgentsAerosol TherapyChemotherapy Drug AdministrationChemotherapy Toxicity ManagementDrug Delivery SystemsPharmacokinetics Of Anticancer DrugsVeterinary ChemotherapyAerosol PenetrationAerosol PharmacokineticsChemotherapy DeliveryIntraperitoneal AdministrationPendulum MotionPenetration DepthPharmacokinetics Of Cytotoxic ChemotherapyTissue Concentration
≤ .05) in all regions except for bowels. In RIPAC, the pharmacokinetic properties reflected hemodynamic changes during capnoperitoneum, and there were no related toxicities. Conclusively, RIPAC may have the potential to enhance drug delivery into the peritoneum compared to PIPAC.
27
APM Heintz, Franco Odicino, Patrick Maisonneuve et al. · International Journal of Gynecology & Obstetrics · 2006 · 1.3K citations
Medicine, Gynecology, Oncology +10
Clinical delivery system for intraperitoneal hyperthermic chemotherapy.
John S. Spratt, Robert A. Adcock, Marie Muskovin et al. · PubMed · 1980 · 481 citations
Reinhold Kerb, Thomas E. Mürdter, Urs Giger-Pabst et al. · Annals of Surgical Oncology · 2013 · 378 citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Hironori Ishigami, Yoshiyuki Fujiwara, Ryoji Fukushima et al. · Journal of Clinical Oncology · 2018 · 356 citations
Medicine, Oncology, Pharmacology +13
Charlotte E.L. Klaver, D D Wisselink, Cornelis J.A. Punt et al. · The Lancet. Gastroenterology & hepatology · 2019 · 322 citations · Full text